Unlock instant, AI-driven research and patent intelligence for your innovation.

Stilbene glucoside medical composition and preparation method thereof

A technology of stilbene glycosides and compositions, which is applied in the field of medicine, can solve problems such as obstacles to the development of finished medicines and difficulties in pharmaceutical compositions, and achieve the effects of convenient and feasible preparation methods and improved stability

Inactive Publication Date: 2013-03-20
NANJING CHIA TAI TIANQING PHARMA
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The easy oxidation of stilbene glycosides makes it very difficult to prepare stable stilbene glycoside pharmaceutical compositions, which hinders the pace of its development into drugs
At present, in the prior art, only two pharmaceutical compositions of Polygonum multiflorum stilbene total glycosides tablet and stilbene glycoside oral liquid have been reported.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Stilbene glucoside medical composition and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Example 1 Effect of Carbohydrates on the Stability of Stilbene Glycoside Pharmaceutical Compositions

[0029] Six batches of stilbene glycoside freeze-dried powder were prepared according to the following method with stilbene glycoside as the active ingredient (content: 99.46%).

[0030] 5.0 g of stilbene glycosides, 0.1 g of sodium bisulfite, 0.1 g of disodium edetate, and 50.0 g of lactose were dissolved in 500 ml of water for injection to form a uniform solution. The 500ml solution is divided into 5 equal parts, that is, sample 1 to sample 5, 100ml / part, sample 1 does not add pH regulator hydrochloric acid, and sample 2 to sample 5 uses 1N hydrochloric acid to adjust the pH value to 6.0, 5.0, 4.0, 3.0 respectively.

[0031] 1.0 g of stilbene glycoside, 0.02 g of sodium bisulfite, and 0.02 g of disodium edetate were dissolved in 100 ml of water for injection, and the pH value was adjusted to 4.0 with 1N hydrochloric acid, which was sample 6.

[0032] Each batch of sa...

Embodiment 2

[0037] Example 2 The influence of pH value on the stability of the stilbene glycoside pharmaceutical composition

[0038] With stilbene glycoside as the active ingredient (content 99.46%), 5 batches of stilbene glycoside freeze-dried powder were prepared according to the following method.

[0039] 5.0 g of stilbene glycosides, 0.1 g of sodium bisulfite, 0.1 g of calcium sodium edetate, and 30.0 g of mannitol were dissolved in 500 ml of water for injection to form a uniform solution. 500ml solution is divided into 5 equal parts, i.e. sample 1 to sample 5, 100ml / part, adjust the pH value to 5.5, 5.0, 4.5, 4.0, 3.5 with 10% phosphoric acid and 10% sodium phosphate solution respectively.

[0040] Each batch of solutions was divided into 10ml vials (2ml / bottle), freeze-dried by a freeze dryer, filled with nitrogen, and capped.

[0041] The prepared freeze-dried sample was subjected to an accelerated test at 40±2°C and RH75%±5%. After 60 days, the properties of the sample were obse...

Embodiment 3

[0045] Example 3 Effects of antioxidants and metal complexes on the stability of the stilbene glycoside pharmaceutical composition

[0046] Using stilbene glycoside as the active ingredient (content 99.46%), 4 batches of stilbene glycoside freeze-dried powder injections were prepared as follows.

[0047] 3.0 g of stilbene glycosides, 0.3 g of vitamin C, 0.3 g of calcium sodium edetate, and 30.0 g of lactose were dissolved in 300 ml of water for injection to form a uniform solution. The 300ml solution was equally divided into 3 equal parts, that is, sample 1 to sample 3, 100ml / part, and the pH value was adjusted to 5.0, 4.5, 4.0 with 10% citric acid and 10% sodium citrate solution respectively.

[0048] 1.0 g of stilbene glycosides and 10.0 g of lactose were dissolved in 100 ml of water for injection, and the pH value was adjusted to 4.5 with 10% citric acid and 10% sodium citrate solution, which was sample 4.

[0049] Each batch of solutions was divided into 10ml vials (2ml / b...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a stilbene glucoside medical composite and a preparation method thereof. The stability of the medical composite in the solid state or the liquid state is greatly improved; and the preparation method is convenient and feasible and is suitable for industrial production.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a stilbene glycoside pharmaceutical composition and a preparation method thereof. Background technique [0002] The stilbene compounds that exist in nature are called phytoalexins, which are produced by the special immune response of the plant immune system when it is attacked by the outside world (such as bacteria, viruses, light radiation, etc.). Due to its diverse physiological activities, it has always been prepared attention. Stilbene glycosides, also known as stilbene polyphenols, are polyhydroxy stilbene compounds that are widely found in mosses and higher plants. In recent years, many literatures have reported that stilbene glycosides have a variety of physiological activities and medicinal values, and have shown good activities in reducing blood lipids, inhibiting tumors, anti-oxidation, and treating ischemic cardiovascular and cerebrovascular diseases. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/7034A61K47/26A61K47/18A61K47/02A61K47/22A61P39/06A61P3/06A61P35/00A61P9/10
Inventor 石赟蓉董李娜郭安军王衡奇张喜全
Owner NANJING CHIA TAI TIANQING PHARMA